Key result
Elderly patients aged 75 years and older with STEMI had a higher two-week in-hospital mortality rate (20.2%) compared to younger patients aged 50-70 years (6.5%).
Why the study?
Does advanced age (≥75 years) worsen clinical presentation, management, and mortality in patients with STEMI compared to younger patients (50-70 years)?
Case-Control (n=952)
No
Does advanced age (≥75 years) worsen clinical presentation, management, and mortality in patients with STEMI compared to younger patients (50-70 years)?
Absolute Event Rate: 20.2% vs 6.5%
Elderly patients with STEMI present later, have more atypical symptoms, receive less reperfusion therapy, and have significantly higher in-hospital mortality and bleeding complications compared to younger patients.
Highlights excess short-term mortality in elderly STEMI; leaves open whether age-specific protocols improve outcomes.
BACKGROUND: ST elevation myocardial infarction (STEMI) in old and old-old patients presents several peculiarities in natural history, delay of hospitalization and response to treatment. Aim of this retrospective case control study was to determine presentation, complications and management of elderly patients with STEMI compared to a younger population. METHODS: 462 patients (205 M and 257 F) aged > or =75 years, hospitalized in CCU between 1999 and 2003 for STEMI, were evaluated. The control group consisted of 490 consecutive patients (268 M and 222 F) aged 50-70 years. Attention was focused on clinical presentation, complications, management and outcome in elderly compared with younger patients. RESULTS: The mean interval between the onset of symptoms and the arrive in CCU was of 9 hour in the elderly compared to 4,5 hour in the control. Chest pain was less frequent (50% vs 90%) in the elderly; the prevalence of dyspnoea and neurological symptoms was higher in patients >75 years (30% vs. 15% and 25% vs. 10%). In the elderly, previous angina and AMI, cerebral and peripheral vascular diseases, peripheral and renal failure were frequent. Early severe complications prevailed in the elderly. Thrombolysis was performed only in 39% of the elderly compared to 65% of the control. Significantly higher was cerebral haemorrhage after thrombolysis (4.9% vs. 1.8%). Comparable were the mayor extra cranial bleedings. Primary or facilitated PTCA was performed in few patients in the last year. Two weeks mortality was 20%, compared to 6.5% in the control group. CONCLUSION: The patients >75 years with STEMI were hospitalized later, had atypical presentation with less chest pain and more cardiac failure, were less likely to receive thrombolysis, had more complications and more cerebral bleedings. Elderly had more associated diseases and in-hospital mortality was higher.
No takes yet. Share an insight, caveat, or question.
Corsini et al. (2016) conducted a case-control in ST elevation myocardial infarction (STEMI) (n=952). Advanced age (≥75 years) vs. Younger age (50-70 years) was evaluated on Two weeks in-hospital mortality. Elderly patients aged 75 years and older with STEMI had a higher two-week in-hospital mortality rate (20.2%) compared to younger patients aged 50-70 years (6.5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: